Kiromic BioPharma, Inc. Short Interest Up 21.5 percent in June
| KRBPDelisted Stock | USD 2.68 0.07 2.55% |
Slightly above 62% of Kiromic Biopharma's investor base is looking to short. The analysis of overall sentiment of trading Kiromic Biopharma stock suggests that many investors are alarmed at this time. Kiromic Biopharma's investing sentiment overview a quick insight into current market opportunities from investing in Kiromic Biopharma. Many technical investors use Kiromic Biopharma stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Kiromic |
Kiromic BioPharma, Inc. was the recipient of a significant growth in short interest during the month of June. As of June 15th, there was short interest totalling 41,300 shares, a growth of 21.5 percent from the May 31st total of 34,000 shares. Currently, 3.7 percent of the shares of the stock are short
Read at thelincolnianonline.com
 |
Kiromic Biopharma Fundamental Analysis
We analyze Kiromic Biopharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kiromic Biopharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kiromic Biopharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Return On Equity
Return On Equity Comparative Analysis
Kiromic Biopharma is currently under evaluation in return on equity category among its peers. Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Kiromic Biopharma Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Kiromic Biopharma stock to make a market-neutral strategy. Peer analysis of Kiromic Biopharma could also be used in its relative valuation, which is a method of valuing Kiromic Biopharma by comparing valuation metrics with similar companies.
Peers
Kiromic Biopharma Related Equities
| QNRX | Quoin Pharmaceuticals | 28.12 | ||||
| CYTO | Altamira Therapeutics | 11.63 | ||||
| IMMX | Immix Biopharma | 11.44 | ||||
| BDRX | Biodexa Pharmaceticals | 7.86 | ||||
| ENVB | Enveric Biosciences | 3.13 | ||||
| ALLR | Allarity Therapeutics | 1.82 | ||||
| ZVSA | ZyVersa Therapeutics | 2.91 | ||||
| RVPH | Reviva Pharmaceuticals | 3.23 | ||||
| ZURA | Zura Bio | 3.57 | ||||
| UNCY | Unicycive Therapeutics | 4.05 | ||||
| VRAX | Virax Biolabs | 4.62 | ||||
| PALI | Palisade Bio | 5.00 | ||||
| SONN | Sonnet Biotherapeutics | 7.66 |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Consideration for investing in Kiromic Stock
If you are still planning to invest in Kiromic Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kiromic Biopharma's history and understand the potential risks before investing.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |